Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.
about
Incidence of type 2 diabetes in Aboriginal Australians: an 11-year prospective cohort studyMetformin for people with impaired glucose tolerance or impaired fasting blood glucoseChinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucoseWhole grain foods for the prevention of type 2 diabetes mellitusAlpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucoseWhole grain foods for the prevention of type 2 diabetes mellitusAlpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucoseEffects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretionTreating prediabetes with metformin: systematic review and meta-analysisChange in fasting plasma glucose and incident type 2 diabetes mellitus: results from a prospective cohort studyProgression from newly acquired impaired fasting glusose to type 2 diabetesToward prevention and control of type 2 diabetes: challenges at the U.S.-Mexico border and beyondTreatment of prediabetesBMI cut points to identify at-risk Asian Americans for type 2 diabetes screeningCoronary atherosclerosis is already ongoing in pre-diabetic status: Insight from intravascular imaging modalitiesUpdate on pre-diabetes: Focus on diagnostic criteria and cardiovascular riskTen-year Diabetes Risk Forecast in the Capital of Jordan: Arab Diabetes Risk Assessment Questionnaire Perspective-A Strobe-Complaint ArticleCross-sectional and prospective study of the association between lung function and prediabetesSex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes MellitusAssociation of serum uric acid with 2-hour postload glucose in Chinese with impaired fasting plasma glucose and/or HbA1cReduced glycaemic and insulinaemic responses following trehalose and isomaltulose ingestion: implications for postprandial substrate use in impaired glucose-tolerant subjectsOverweight and abdominal obesity as determinants of undiagnosed diabetes and pre-diabetes in Bangladesh.Effectively translating diabetes prevention: a successful model in a historically underserved communityImpaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis)Direct evidence for the economy of action: glucose and the perception of geographical slant.Positive predictive value of a case definition for diabetes mellitus using automated administrative health data in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid studyThe association of genetic markers for type 2 diabetes with prediabetic status - cross-sectional data of a diabetes prevention trial.Prevalence, awareness and control of diabetes in the Seychelles and relationship with excess body weight.Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project.High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study.Three years follow-up of screen-detected diabetic and non-diabetic subjects: who is better off? The ADDITION Netherlands study.Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran.The characteristics of impaired fasting glucose associated with obesity and dyslipidaemia in a Chinese population.Meaning of upper limit of normal range of post-load 1-h plasma glucose level defined by oral glucose tolerance test in Japanese subjects.Plasma glucose concentration and prediction of future risk of type 2 diabetes.Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels.Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjectsMetabolic syndrome and the early detection of impaired glucose tolerance among professionals living in Beijing, China: a cross sectional study.One-hour plasma glucose identifies insulin resistance and beta-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study.Minimal contribution of fasting hyperglycemia to the incidence of type 2 diabetes in subjects with normal 2-h plasma glucose.
P2860
Q21260237-2294D841-335D-414B-9B04-0964BAB077D9Q24235225-08EBDEFA-0C72-4284-B2E6-DB5EC08E4E92Q24240715-5EA9A372-AE26-4807-B5CD-E2F3DA2875FAQ24242693-07DEF529-2E01-445A-846F-196985BA4F49Q24244041-BAA62E46-E6B0-4717-A8DC-EF0A1C2AA055Q24244371-F831E1C7-BF96-40DE-AD05-603C4BB3B994Q24246432-FA9BB252-1B89-4E27-B3EA-B2400953F157Q24293522-B56B5342-1F69-4A67-861D-9F647AD01019Q24642274-C012BD38-A74E-4A51-A2FC-E6BBA606DA31Q24658670-EAE97749-529E-4686-8766-47DD5DAEE701Q24683882-8EFFD1A4-5E0C-44C3-BAE2-49EC2AB08476Q25255622-D2129294-B8A1-4546-8B01-026153DF4F2CQ26783350-C8A76A2D-D9C4-467F-A190-40B86DA4F6C3Q26851467-0B4C293E-4015-4844-9B44-AD24966D30C2Q26866204-950D4123-E384-43FA-9ABA-774A26BE2A98Q28073749-DCF9EE85-9A8E-4C2B-8FD3-A69BEAACB733Q28387551-34A4BFD8-89AD-43BB-810D-CDD861B0D794Q28395087-5DD426D6-0E06-4FC4-8E64-2592990CBE3AQ28395801-E3F74028-FFC6-4154-BC93-4AE63AA9353FQ28534505-8BDF3F92-449E-49EE-A76D-A11BE12B93DAQ29999875-BF9A3C94-FD6A-4C38-ACF8-1BDBD0473930Q30385949-9B822E58-B75F-4969-B74C-3066801D2ADAQ30410938-5B30EC03-9AB4-40EA-AB3B-CF4107607D58Q30426085-C2AACD91-7B67-4666-8883-BD775CEBE09DQ30427904-76CE1724-FA2F-4F04-9712-FDA0CE8D7736Q30559039-50161061-9B40-480D-824A-021CF2DC1800Q30671574-73DFF840-694C-4F33-975F-E2DE38D38968Q33291269-52D7F950-8814-4499-869C-859FD6E81350Q33299400-AAA83485-0523-4DBB-BAAE-8B70C59F0B9FQ33337490-2D03B2D6-5DB6-4A51-BD5A-9BBC609159E7Q33393473-33A48A54-19A4-471A-BBF3-B3FFD892694DQ33468715-D817E863-6B5E-446D-9D8A-508B5E701FE8Q33541335-8BBB1E90-A3E6-40FA-ADBC-243895CCF6B3Q33607630-CE10705A-1B85-42B5-BE58-176093AAD8DEQ33610774-E18431A7-3B62-46C2-A53E-7B6301726DE7Q33624365-9D297721-2ED5-429B-8474-795F2692DB77Q33632213-9B4B6434-9E9A-41E7-A5E9-A070FFC8D0DCQ33644612-8B17636A-A5ED-4CC3-A7DC-97F8B61DD41CQ33678580-B9D7BA91-A54D-47EA-BA9F-B51C91C3D1B3Q33683685-5B8D0386-1848-4989-A1E7-1EBC065C1302
P2860
Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Impaired glucose tolerance and ...... n definition and intervention.
@ast
Impaired glucose tolerance and ...... n definition and intervention.
@en
Impaired glucose tolerance and ...... n definition and intervention.
@nl
type
label
Impaired glucose tolerance and ...... n definition and intervention.
@ast
Impaired glucose tolerance and ...... n definition and intervention.
@en
Impaired glucose tolerance and ...... n definition and intervention.
@nl
prefLabel
Impaired glucose tolerance and ...... n definition and intervention.
@ast
Impaired glucose tolerance and ...... n definition and intervention.
@en
Impaired glucose tolerance and ...... n definition and intervention.
@nl
P2093
P2860
P1433
P1476
Impaired glucose tolerance and ...... n definition and intervention.
@en
P2093
P2860
P304
P356
10.1046/J.1464-5491.2002.00835.X
P577
2002-09-01T00:00:00Z